Increased NFκB activity has been observed in CRC (Hardwick et al, 2001) and relative resistance to apoptosis has been attributed to high constitutive NFκB activity in other cancers (Bours et al, 1994; Lind et al, 2001; Charalambous et al, 2003). This evidence concerns the gene NFKB1 and cancer.